Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree - PubMed (original) (raw)

Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree

Kenichi Harada et al. Hepatology. 2004 Oct.

Abstract

Human beta-defensins (hBDs) are important antimicrobial peptides that contribute to innate immunity at mucosal surfaces. This study was undertaken to investigate the expression of hBD-1 and hBD-2 in intrahepatic biliary epithelial cells in specimens of human liver, and 4 cultured cell lines (2 consisting of biliary epithelial cells and 2 cholangiocarcinoma cells). In addition, hBD-1 and hBD-2 were assayed in specimens of bile. hBD-1 was nonspecifically expressed immunohistochemically in intrahepatic biliary epithelium and hepatocytes in all patients studied, but expression of hBD-2 was restricted to large intrahepatic bile ducts in 8 of 10 patients with extrahepatic biliary obstruction (EBO), 7 of 11 with hepatolithiasis, 1 of 6 with primary biliary cirrhosis (PBC), 1 of 5 with primary sclerosing cholangitis (PSC), 0 of 6 with chronic hepatitis C (CH-C), and 0 of 11 with normal hepatic histology. hBD-2 expression was evident in bile ducts exhibiting active inflammation. Serum C reactive protein levels correlated with biliary epithelial expression of hBD-2. Real-time PCR revealed that in all of 28 specimens of fresh liver, including specimens from patients with hepatolithiasis, PBC, PSC, CH-C and normal hepatic histology, hBD-1 messenger RNA was consistently expressed, whereas hBD-2 messenger RNA was selectively expressed in biliary epithelium of patients with hepatolithiasis. Immunobloting analysis revealed hBD-2 protein in bile in 1 of 3 patients with PSC, 1 of 3 with PBC, and each of 6 with hepatolithiasis; in contrast, hBD-1 was detectable in all bile samples examined. Four cultured biliary epithelial cell lines consistently expressed hBD-1; in contrast these cell lines did not express hBD-2 spontaneously but were induced to express hBD-2 by treatment with Eschericia coli, lipopolysaccharide, interleukin-1beta or tumor necrosis factor-alpha. In conclusion, these findings suggest that in the intrahepatic biliary tree, hBD-2 is expressed in response to local infection and/or active inflammation, whereas hBD-1 may constitute a preexisting component of the biliary antimicrobial defense system.

PubMed Disclaimer

Similar articles

• IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules.
  Isse K, Harada K, Nakanuma Y. Isse K, et al. Liver Int. 2007 Jun;27(5):672-80. doi: 10.1111/j.1478-3231.2007.01465.x. Liver Int. 2007. PMID: 17498253
• Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
  Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y. Isse K, et al. Hepatology. 2005 Mar;41(3):506-16. doi: 10.1002/hep.20582. Hepatology. 2005. PMID: 15726664
• Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
  Tsuneyama K, Kono N, Yamashiro M, Kouda W, Sabit A, Sasaki M, Nakanuma Y. Tsuneyama K, et al. J Pathol. 1999 Dec;189(4):609-14. doi: 10.1002/(SICI)1096-9896(199912)189:4<609::AID-PATH474>3.0.CO;2-2. J Pathol. 1999. PMID: 10629565
• Heterogeneity of the intrahepatic biliary epithelium.
  Glaser S, Francis H, Demorrow S, Lesage G, Fava G, Marzioni M, Venter J, Alpini G. Glaser S, et al. World J Gastroenterol. 2006 Jun 14;12(22):3523-36. doi: 10.3748/wjg.v12.i22.3523. World J Gastroenterol. 2006. PMID: 16773709 Free PMC article. Review.
• Pathology and pathogenesis of intrahepatic bile duct loss.
  Nakanuma Y, Tsuneyama K, Harada K. Nakanuma Y, et al. J Hepatobiliary Pancreat Surg. 2001;8(4):303-15. doi: 10.1007/s005340170002. J Hepatobiliary Pancreat Surg. 2001. PMID: 11521175 Review.

Cited by

• Advances in cholangiocyte immunobiology.
  Syal G, Fausther M, Dranoff JA. Syal G, et al. Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15;303(10):G1077-86. doi: 10.1152/ajpgi.00227.2012. Epub 2012 Sep 6. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22961800 Free PMC article. Review.
• The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
  Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL. Kawata K, et al. Clin Rev Allergy Immunol. 2012 Dec;43(3):230-41. doi: 10.1007/s12016-012-8324-0. Clin Rev Allergy Immunol. 2012. PMID: 22689287 Review.
• Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
  Giordano DM, Pinto C, Maroni L, Benedetti A, Marzioni M. Giordano DM, et al. Int J Mol Sci. 2018 Oct 1;19(10):3003. doi: 10.3390/ijms19103003. Int J Mol Sci. 2018. PMID: 30275402 Free PMC article. Review.
• Cholangiocyte pathobiology.
  Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Banales JM, et al. Nat Rev Gastroenterol Hepatol. 2019 May;16(5):269-281. doi: 10.1038/s41575-019-0125-y. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30850822 Free PMC article. Review.
• Human β-Defensin 2 in Primary Sclerosing Cholangitis.
  Chang C, Lleo A, Kananurak A, Grizzi F, Tsuneyama K, Invernizzi P, Bevins CL, Bowlus CL. Chang C, et al. Clin Transl Gastroenterol. 2017 Mar 16;8(3):e80. doi: 10.1038/ctg.2017.8. Clin Transl Gastroenterol. 2017. PMID: 28300822 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program
  • National BioResource Project